0
Department of Health and Human Services Awarded a Contract to AURAVAX THERAPEUTICS, INC. for $749,999.00
Signed on
9/16/2024, 12:00 AM
AURAVAX THERAPEUTICS, INC. Government Contract #75A50124C00054
AURAVAX THERAPEUTICS, INC. was awarded a contract with the United States Government for $749,999.00. The contract was awarded by the agency office BARDA - ASPR / DAAPPO / BARDA DCMA, which is a division with the Office of Assistant Secretary for Preparedness and Response within the Department of Health and Human Services.
Summary of Award
The recipient of the federal contract is AURAVAX THERAPEUTICS, INC., based in Houston, Texas. The contract, funded by the Department of Health and Human Services, is for assessing a novel mucosal adjuvant in combination with influenza live attenuated virus for a total amount of $749,999. Notable details include a single offer received, full and open competition, and a firm fixed price contract.
Contract Details
Agency Details
Recipient Details
Comments
Award Transactions
Office of Assistant Secretary for Preparedness and Response, a sub agency of Department of Health and Human Services, issued a payment of $0.00 to AURAVAX THERAPEUTICS, INC.. The payment included a Subsidy Cost of $0.00.
This payment could indicate a change to the existing contract.
Office of Assistant Secretary for Preparedness and Response, a sub agency of Department of Health and Human Services, issued a payment of $0.00 to AURAVAX THERAPEUTICS, INC.. The payment included a Subsidy Cost of $0.00.
This payment could indicate a change to the existing contract.
Office of Assistant Secretary for Preparedness and Response, a sub agency of Department of Health and Human Services, issued a payment of $749,999.00 to AURAVAX THERAPEUTICS, INC.. The payment included a Subsidy Cost of $0.00.